Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 2/3 × Uterine Cervical Dysplasia × Imiquimod × Clear all

Phase

Phase NA 3 Phase 2/3 2 Phase 2 2 Phase 1 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Uterine Cervical Dysplasia 2 Melanoma 1 Hutchinson's Melanotic Freckle 1 Bowen's Disease 1

Interventions

Imiquimod 2 ZYC101a 1 Vaginal Smears 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02130323 2017-06-27

Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix

United States Naval Medical Center, San Diego

Phase 2/3 Completed

Uterine Cervical Dysplasia

NCT00941252 2011-01-24

ITIC

Medical University of Vienna

Phase 2/3 Completed

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡